content: <PAGE>   1
              As filed with the Securities and Exchange Commission
                             on September 27, 1996.
                                                   Registration No. 333- _________
  ================================================================================
  
                         SECURITIES AND EXCHANGE COMMISSION
                              Washington, D.C.  20549
  
                                      FORM S-8
  
              REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933
  
                              WANG LABORATORIES, INC.
                 (Exact name of issuer as specified in its charter)
  
  
                  DELAWARE                                     04-2192707
      (State or other jurisdiction of                       (I.R.S. Employer
       incorporation or organization)                    Identification Number)
                                                         
         600 TECHNOLOGY PARK DRIVE                               01821
          BILLERICA, MASSACHUSETTS                       
  (Address of Principal Executive Offices)                     (Zip Code)
  
                                    I-NET, INC.
                             1996 STOCK INCENTIVE PLAN
  
                              (Full title of the Plan)
  
                               ALBERT A. NOTINI, ESQ.
                              WANG LABORATORIES, INC.
                             600 TECHNOLOGY PARK DRIVE
                           BILLERICA, MASSACHUSETTS 01821
                      (Name and address of agent for service)
  
                                   (508) 967-5000
           (Telephone number, including area code, of agent for service)     
  
  <TABLE>
  <CAPTION>
  - ---------------------------------------------------------------------------------
                          CALCULATION OF REGISTRATION FEE
  
                                Proposed
  Title of         Amount       maximum         Proposed maximum
  securities to    to be        offering price  aggregate          Amount of
  be registered    registered   per share       offering price     registration fee
  - --------------   ----------   --------------  ----------------   ----------------
  <S>              <C>          <C>             <C>                <C>
  Common Stock,    247,489      $11.14(1)       $2,757,027.46(1)   $950.70
  $.01 par value   shares
  per share                                                                
  - ---------------------------------------------------------------------------------
  <FN>
  
  (1)      All shares are issuable upon the exercise of outstanding options with
           fixed exercise prices.  Pursuant to Rule 457(h)(1) of the Securities
           Act of 1933, the aggregate offering price and the fee have been
           computed upon the basis of the prices at which the options may be
           exercised.  The offering price per share set forth for such shares is
           the weighted average of the exercise prices per share at which such
           options are exercisable.  All of the options granted pursuant to this
           plan are being registered hereby.  There will be no additional grants
           under the plan in the future.
  </TABLE>
  
  ================================================================================
  <PAGE>   2
  PART I.  INFORMATION REQUIRED IN THE SECTION 10(a) PROSPECTUS
  
                   The information required by Part I of Form S-8 is included in
  documents sent or given to participants in Registrant's I-Net 1996 Stock
  Incentive Plan pursuant to Rule 428(b)(1) of the Securities Act of 1933, as
  amended (the "Securities Act").
  
  PART II. INFORMATION REQUIRED IN THE REGISTRATION STATEMENT
  
           Item 3. Incorporation of Certain Documents by Reference
                   -----------------------------------------------
  
                   Wang Laboratories, Inc. (the "Registrant") is subject to the
  informational and reporting requirements of Sections 13(a), 14 and 15(d) of the
  Securities and Exchange Act of 1934, as amended(the "Exchange Act"), and in
  accordance therewith files reports, proxy statements and other information with
  the Securities and Exchange Commission (the "Commission").  The following
  documents, which are filed with the Commission, are incorporated in this
  Registration Statement by reference:
  
                   (1)      The Registrant's latest annual report filed pursuant
           to Sections 13(a) or 15(d) of the Exchange Act, or the latest
           prospectus filed pursuant to Rule 424(b) under the Securities Act that
           contains audited financial statements for the Registrant's latest
           fiscal year for which such statements have been filed.
  
                   (2)      All other reports filed pursuant to Sections 13(a) or
           15(d) of the Exchange Act since the end of the fiscal year covered by
           the annual report or the prospectus referred to in (1) above.
  
                   (3)      The description of the common stock of the
           Registrant, $.01 par value per share (the "Common Stock"), contained
           in a Registration Statement filed under the Exchange Act, including
           any amendment or report filed for the purpose of updating such
           description.
  
                   All documents subsequently filed by the Registrant pursuant to
  Sections 13(a), 13(c), 14, and 15(d) of the Exchange Act, prior to the filing
  of a post-effective amendment which indicates that all securities offered have
  been sold or which deregisters all shares of Common Stock then remaining
  unsold, shall be deemed to be incorporated by reference herein and to be part
  hereof from the date of the filing of such documents.
  
           Item 4. Description of Securities
                   -------------------------
  
                   Not applicable.
  
           Item 5. Interests of Names Experts and Counsel
                   --------------------------------------
  
                   Not applicable.
  
           Item 6. Indemnification
                   ---------------
  
           Section 102 of the Delaware General Corporation Law, as amended,
  allows a corporation to eliminate the personal liability of directors of a
  corporation to the corporation or its stockholders for monetary damages for a
  breach of fiduciary duty as a director, except where the director breached his
  or her duty of loyalty, failed to act in good faith, engaged in intentional
  misconduct or knowingly violated a law, authorized the payment of a dividend or
  approved a stock repurchase in violation of Delaware corporate law or obtained
  an improper personal benefit.
  
           Section 145 of the Delaware General Corporation Law authorizes a court
  to award, or a corporation's Board of Directors to grant, indemnification to
  directors and officers in terms sufficiently broad to permit such
  indemnification under certain circumstances for liabilities (including
  <PAGE>   3
  reimbursement for expenses incurred) arising under the Securities Act of 1933,
  as amended (the "Securities Act").
  
           Article TENTH of Registrant's Certificate of Incorporation provides
  for indemnification of its directors and officers to the maximum extent
  permitted by the Delaware General Corporation Law.
  
           Item 7. Exemption from Registration Claimed
                   -----------------------------------
  
                   Not applicable.
  
           Item 8. Exhibits
                   --------
  
                   The Exhibit Index immediately preceding the exhibits is
  incorporated herein by reference.
  
           Item 9. Undertakings
                   ------------
  
           1.      The Registrant hereby undertakes:
  
                   (1)      To file, during any period in which offers or sales
           are being made, a post-effective amendment to this Registration
           Statement:
  
                   (i)      To include any prospectus required by Section
           10(a)(3) of the Securities Act;
  
                   (ii)     To reflect in the prospectus any facts or events
           arising after the effective date of the Registration Statement (or the
           most recent post-effective amendment thereof) which, individually or
           in the aggregate, represent a fundamental change in the information
           set forth in the Registration Statement; and
  
                   (iii)    To include any material information with respect to 
           the plan of distribution not previously disclosed in the Registration
           Statement or any material change to such information in the
           Registration Statement;
  
                   PROVIDED, HOWEVER, that paragraphs (i) and (ii) do not apply
           if the Registration Statement is on Form S-3 or Form S-8, and the
           information required to be included in a post-effective amendment by
           those paragraphs is contained in periodic reports filed with or
           furnished to the Commission by the Registrant pursuant to Section 13
           or Section 15(d) of the Exchange Act that are incorporated by
           reference in the Registration Statement.
  
                   (2)      That, for the purposes of determining any liability
           under the Securities Act, each such post-effective amendment shall be
           deemed to be a new Registration Statement relating to the securities
           offered therein, and the offering of such securities at that time
           shall be deemed to be the initial bona fide offering thereof.
  
                   (3)      To remove from registration by means of a
           post-effective amendment any of the securities being registered which
           remain unsold at the termination of the offering.
  
           2.      The Registrant hereby undertakes that, for purposes of
  determining any liability under the Securities Act, each filing of the
  Registrant's annual report pursuant to Section 13(a) or Section 15(d) of the
  Exchange Act (and, where applicable, each filing of an employee benefit plan's
  annual report pursuant to Section 15(d) of the Exchange Act) that is
  incorporated by reference in the Registration Statement shall be deemed to be a
  new Registration Statement relating to the securities offered therein, and the
  offering of such securities at that time shall be deemed to be the initial bona
  fide offering thereof.
  <PAGE>   4
           3.      Insofar as indemnification for liabilities arising under the
  Securities Act may be permitted to directors, officers and controlling persons
  of the Registrant pursuant to the foregoing provisions, or otherwise, the
  Registrant has been advised that in the opinion of the Securities and Exchange
  Commission such indemnification is against public policy as expressed in the
  Securities Act and is, therefore, unenforceable.  In the event that a claim for
  indemnification against such liabilities (other than the payment by the
  Registrant of expenses incurred or paid by a director, officer or controlling
  person of the Registrant in the successful defense of any action, suit or
  proceeding) is asserted by such director, officer or controlling person in
  connection with the securities being registered, the Registrant will, unless in
  the opinion of its counsel the matter has been settled by controlling
  precedent, submit to a court of appropriate jurisdiction the question whether
  such indemnification by it is against public policy as expressed in the
  Securities Act and will be governed by the final adjudication of such issue.
  <PAGE>   5
                                     SIGNATURES
  
           Pursuant to the requirements of the Securities Act of 1933, the
  Registrant certifies that it has reasonable grounds to believe that it meets
  all of the requirements for filing on Form S-8 and has duly caused this
  Registration Statement to be signed on its behalf of the undersigned, thereunto
  duly authorized, in the Town of Billerica, Commonwealth of Massachusetts, on
  this 27th day of September, 1996
  
                                          WANG LABORATORIES, INC.
                                          
                                          
                                          By: /s/ Franklyn A. Caine
                                              -----------------------------------
                                              Franklyn A. Caine
                                              Executive Vice President and
                                                Chief Financial Officer
  
  
                                 POWER OF ATTORNEY
  
           We, the undersigned officers and directors of Wang Laboratories, Inc.
  hereby severally constitute Albert A.  Notini and John A. Burgess, and each of
  them singly, our true and lawful attorneys with full power to them, and each of
  them singly, to sign for us and in our names in the capacities indicated below,
  the Registration Statement on Form S-8 filed herewith and any and all
  subsequent amendments to said Registration Statement, and generally to do all
  such things in our names and behalf in our capacities as officers and directors
  to enable Wang Laboratories, Inc. to comply with all requirements of the
  Securities and Exchange Commission, hereby ratifying and confirming our
  signatures as they may be signed by said attorneys, or any of them, to said
  Registration Statement and any and all amendments thereto.
  
  <TABLE>
  
           Pursuant to the requirements of the Securities Act of 1933, this
  Registration Statement has been signed by the following persons in the
  capacities and on the dates indicated:
  
  <CAPTION>
  Signature                  Title                             Date
  - ---------                  -----                             ----         
  <S>                        <C>                               <C>
  /s/ Joseph M. Tucci        Chairman of the Board, Chief      September 27, 1996
  - -----------------------    Executive Officer and Director
  Joseph M. Tucci            (Principal Executive Officer)
  
  
  /s/ Franklyn A. Caine      Executive Vice President and      September 27, 1996
  - -----------------------    Chief Financial Officer
  Franklyn A. Caine          (Principal Financial Officer)
                             
  
  /s/ Gregory C. Thompson    Vice President and Corporate      September 27, 1996
  - -----------------------    Controller
  Gregory C. Thompson        (Principal Accounting Officer)
                             
  
  /s/ David A. Boucher       Director                          September 27, 1996
  - -----------------------
  David A. Boucher
  
  
  /s/ Michael W. Brown       Director                          September 27, 1996
  - -----------------------
  Michael W. Brown
  
  
  /s/ Marcia J. Hooper       Director                          September 27, 1996
  - -----------------------
  Marcia J. Hooper
  
  
  /s/ Joseph J. Kroger       Director                          September 27, 1996
  - -----------------------
  Joseph J. Kroger
  
  
  /s/ Raymond C. Kurzweil    Director                          September 27, 1996
  - -----------------------
  Raymond C. Kurzweil
  </TABLE>
  <PAGE>   6
  <TABLE>
  <S>                        <C>                               <C>
  /s/ Axel J. Leblois        Director                          September 27, 1996
  - -----------------------
  Axel J. Leblois
  
  
  /s/ Paul E. Tsongas        Director                          September 27, 1996
  - -----------------------
  Paul E. Tsongas
  
  
  /s/ Frederick A. Wang      Director                          September 27, 1996
  - -----------------------
  Frederick A. Wang
  </TABLE>
  <PAGE>   7
  
                                   EXHIBIT INDEX
  
  <TABLE>
  <S>     <C> 
  4.1*    Certificate of Incorporation of the Registrant, as amended to date
  4.2*    By-Laws of the Registrant, as amended to date
  5.1     Opinion of Albert A. Notini, General Counsel of Wang Laboratories, Inc.
  23.1    Consent of Albert A. Notini, General Counsel of Wang Laboratories, 
          Inc. (included in Exhibit 5.1)
  23.2    Consent of Ernst & Young, LLP
  24.1    Power of Attorney (included on page 5 of the Registration Statement)
  
  
  <FN>
  
  - ---------------
  *       Filed as an Exhibit to the Registrant's quarterly report on 10-Q for
          the quarter ended December 31, 1995 and incorporated herein by
          reference.
  </TABLE>
metadata_documents: [{"type": "S-8", "sequence": "1", "description": "WANG -- I-NET, INC. 1996 STOCK INCENTIVE PLAN", "secsgml_size_bytes": 16074}]
metadata_filer: {"company-data": {"conformed-name": "WANG LABORATORIES INC", "cik": "0000104519", "assigned-sic": "7372", "irs-number": "042192707", "state-of-incorporation": "DE", "fiscal-year-end": "0630"}, "filing-values": {"form-type": "S-8", "act": "33", "file-number": "333-12943", "film-number": "96636281"}, "business-address": {"street1": "600 TECHNOLOGY PARK DRIVE", "city": "BILLERICA", "state": "MA", "zip": "01821-4120", "phone": "5089675000"}, "mail-address": {"street1": "600 TECHNOLOGY PARK DRIVE", "street2": "MAILSTOP 014-B3C", "city": "BILLERICA", "state": "MA", "zip": "01821-4120"}}
text: 1
              As filed with the Securities and Exchange Commission
                             on September 27, 1996.
                                                   Registration No. 333- _________
  ================================================================================
  
                         SECURITIES AND EXCHANGE COMMISSION
                              Washington, D.C.  20549
  
                                      FORM S-8
  
              REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933
  
                              WANG LABORATORIES, INC.
                 (Exact name of issuer as specified in its charter)
  
                  DELAWARE                                     04-2192707
      (State or other jurisdiction of                       (I.R.S. Employer
       incorporation or organization)                    Identification Number)
                                                         
         600 TECHNOLOGY PARK DRIVE                               01821
          BILLERICA, MASSACHUSETTS                       
  (Address of Principal Executive Offices)                     (Zip Code)
  
                                    I-NET, INC.
                             1996 STOCK INCENTIVE PLAN
  
                              (Full title of the Plan)
  
                               ALBERT A. NOTINI, ESQ.
                              WANG LABORATORIES, INC.
                             600 TECHNOLOGY PARK DRIVE
                           BILLERICA, MASSACHUSETTS 01821
                      (Name and address of agent for service)
  
                                   (508) 967-5000
           (Telephone number, including area code, of agent for service)
  - ---------------------------------------------------------------------------------
                          CALCULATION OF REGISTRATION FEE
  
                                Proposed
  Title of         Amount       maximum         Proposed maximum
  securities to    to be        offering price  aggregate          Amount of
  be registered    registered   per share       offering price     registration fee
  - --------------   ----------   --------------  ----------------   ----------------
  Common Stock,    247,489      $11.14(1)       $2,757,027.46(1)   $950.70
  $.01 par value   shares
  per share                                                                
  - ---------------------------------------------------------------------------------
  (1)      All shares are issuable upon the exercise of outstanding options with
           fixed exercise prices.  Pursuant to Rule 457(h)(1) of the Securities
           Act of 1933, the aggregate offering price and the fee have been
           computed upon the basis of the prices at which the options may be
           exercised.  The offering price per share set forth for such shares is
           the weighted average of the exercise prices per share at which such
           options are exercisable.  All of the options granted pursuant to this
           plan are being registered hereby.  There will be no additional grants
           under the plan in the future.
  ================================================================================
  2
  PART I.  INFORMATION REQUIRED IN THE SECTION 10(a) PROSPECTUS
  
                   The information required by Part I of Form S-8 is included in
  documents sent or given to participants in Registrant's I-Net 1996 Stock
  Incentive Plan pursuant to Rule 428(b)(1) of the Securities Act of 1933, as
  amended (the "Securities Act").
  
  PART II. INFORMATION REQUIRED IN THE REGISTRATION STATEMENT
  
           Item 3. Incorporation of Certain Documents by Reference
                   -----------------------------------------------
  
                   Wang Laboratories, Inc. (the "Registrant") is subject to the
  informational and reporting requirements of Sections 13(a), 14 and 15(d) of the
  Securities and Exchange Act of 1934, as amended(the "Exchange Act"), and in
  accordance therewith files reports, proxy statements and other information with
  the Securities and Exchange Commission (the "Commission").  The following
  documents, which are filed with the Commission, are incorporated in this
  Registration Statement by reference:
  
                   (1)      The Registrant's latest annual report filed pursuant
           to Sections 13(a) or 15(d) of the Exchange Act, or the latest
           prospectus filed pursuant to Rule 424(b) under the Securities Act that
           contains audited financial statements for the Registrant's latest
           fiscal year for which such statements have been filed.
  
                   (2)      All other reports filed pursuant to Sections 13(a) or
           15(d) of the Exchange Act since the end of the fiscal year covered by
           the annual report or the prospectus referred to in (1) above.
  
                   (3)      The description of the common stock of the
           Registrant, $.01 par value per share (the "Common Stock"), contained
           in a Registration Statement filed under the Exchange Act, including
           any amendment or report filed for the purpose of updating such
           description.
  
                   All documents subsequently filed by the Registrant pursuant to
  Sections 13(a), 13(c), 14, and 15(d) of the Exchange Act, prior to the filing
  of a post-effective amendment which indicates that all securities offered have
  been sold or which deregisters all shares of Common Stock then remaining
  unsold, shall be deemed to be incorporated by reference herein and to be part
  hereof from the date of the filing of such documents.
  
           Item 4. Description of Securities
                   -------------------------
  
                   Not applicable.
  
           Item 5. Interests of Names Experts and Counsel
                   --------------------------------------
  
                   Not applicable.
  
           Item 6. Indemnification
                   ---------------
  
           Section 102 of the Delaware General Corporation Law, as amended,
  allows a corporation to eliminate the personal liability of directors of a
  corporation to the corporation or its stockholders for monetary damages for a
  breach of fiduciary duty as a director, except where the director breached his
  or her duty of loyalty, failed to act in good faith, engaged in intentional
  misconduct or knowingly violated a law, authorized the payment of a dividend or
  approved a stock repurchase in violation of Delaware corporate law or obtained
  an improper personal benefit.
  
           Section 145 of the Delaware General Corporation Law authorizes a court
  to award, or a corporation's Board of Directors to grant, indemnification to
  directors and officers in terms sufficiently broad to permit such
  indemnification under certain circumstances for liabilities (including
  3
  reimbursement for expenses incurred) arising under the Securities Act of 1933,
  as amended (the "Securities Act").
  
           Article TENTH of Registrant's Certificate of Incorporation provides
  for indemnification of its directors and officers to the maximum extent
  permitted by the Delaware General Corporation Law.
  
           Item 7. Exemption from Registration Claimed
                   -----------------------------------
  
                   Not applicable.
  
           Item 8. Exhibits
                   --------
  
                   The Exhibit Index immediately preceding the exhibits is
  incorporated herein by reference.
  
           Item 9. Undertakings
                   ------------
  
           1.      The Registrant hereby undertakes:
  
                   (1)      To file, during any period in which offers or sales
           are being made, a post-effective amendment to this Registration
           Statement:
  
                   (i)      To include any prospectus required by Section
           10(a)(3) of the Securities Act;
  
                   (ii)     To reflect in the prospectus any facts or events
           arising after the effective date of the Registration Statement (or the
           most recent post-effective amendment thereof) which, individually or
           in the aggregate, represent a fundamental change in the information
           set forth in the Registration Statement; and
  
                   (iii)    To include any material information with respect to 
           the plan of distribution not previously disclosed in the Registration
           Statement or any material change to such information in the
           Registration Statement;
  
                   PROVIDED, HOWEVER, that paragraphs (i) and (ii) do not apply
           if the Registration Statement is on Form S-3 or Form S-8, and the
           information required to be included in a post-effective amendment by
           those paragraphs is contained in periodic reports filed with or
           furnished to the Commission by the Registrant pursuant to Section 13
           or Section 15(d) of the Exchange Act that are incorporated by
           reference in the Registration Statement.
  
                   (2)      That, for the purposes of determining any liability
           under the Securities Act, each such post-effective amendment shall be
           deemed to be a new Registration Statement relating to the securities
           offered therein, and the offering of such securities at that time
           shall be deemed to be the initial bona fide offering thereof.
  
                   (3)      To remove from registration by means of a
           post-effective amendment any of the securities being registered which
           remain unsold at the termination of the offering.
  
           2.      The Registrant hereby undertakes that, for purposes of
  determining any liability under the Securities Act, each filing of the
  Registrant's annual report pursuant to Section 13(a) or Section 15(d) of the
  Exchange Act (and, where applicable, each filing of an employee benefit plan's
  annual report pursuant to Section 15(d) of the Exchange Act) that is
  incorporated by reference in the Registration Statement shall be deemed to be a
  new Registration Statement relating to the securities offered therein, and the
  offering of such securities at that time shall be deemed to be the initial bona
  fide offering thereof.
  4
           3.      Insofar as indemnification for liabilities arising under the
  Securities Act may be permitted to directors, officers and controlling persons
  of the Registrant pursuant to the foregoing provisions, or otherwise, the
  Registrant has been advised that in the opinion of the Securities and Exchange
  Commission such indemnification is against public policy as expressed in the
  Securities Act and is, therefore, unenforceable.  In the event that a claim for
  indemnification against such liabilities (other than the payment by the
  Registrant of expenses incurred or paid by a director, officer or controlling
  person of the Registrant in the successful defense of any action, suit or
  proceeding) is asserted by such director, officer or controlling person in
  connection with the securities being registered, the Registrant will, unless in
  the opinion of its counsel the matter has been settled by controlling
  precedent, submit to a court of appropriate jurisdiction the question whether
  such indemnification by it is against public policy as expressed in the
  Securities Act and will be governed by the final adjudication of such issue.
  5
                                     SIGNATURES
  
           Pursuant to the requirements of the Securities Act of 1933, the
  Registrant certifies that it has reasonable grounds to believe that it meets
  all of the requirements for filing on Form S-8 and has duly caused this
  Registration Statement to be signed on its behalf of the undersigned, thereunto
  duly authorized, in the Town of Billerica, Commonwealth of Massachusetts, on
  this 27th day of September, 1996
  
                                          WANG LABORATORIES, INC.
                                          
                                          
                                          By: /s/ Franklyn A. Caine
                                              -----------------------------------
                                              Franklyn A. Caine
                                              Executive Vice President and
                                                Chief Financial Officer
  
                                 POWER OF ATTORNEY
  
           We, the undersigned officers and directors of Wang Laboratories, Inc.
  hereby severally constitute Albert A.  Notini and John A. Burgess, and each of
  them singly, our true and lawful attorneys with full power to them, and each of
  them singly, to sign for us and in our names in the capacities indicated below,
  the Registration Statement on Form S-8 filed herewith and any and all
  subsequent amendments to said Registration Statement, and generally to do all
  such things in our names and behalf in our capacities as officers and directors
  to enable Wang Laboratories, Inc. to comply with all requirements of the
  Securities and Exchange Commission, hereby ratifying and confirming our
  signatures as they may be signed by said attorneys, or any of them, to said
  Registration Statement and any and all amendments thereto.
  
           Pursuant to the requirements of the Securities Act of 1933, this
  Registration Statement has been signed by the following persons in the
  capacities and on the dates indicated:
  Signature                  Title                             Date
  - ---------                  -----                             ----
  /s/ Joseph M. Tucci        Chairman of the Board, Chief      September 27, 1996
  - -----------------------    Executive Officer and Director
  Joseph M. Tucci            (Principal Executive Officer)
  
  /s/ Franklyn A. Caine      Executive Vice President and      September 27, 1996
  - -----------------------    Chief Financial Officer
  Franklyn A. Caine          (Principal Financial Officer)
                             
  
  /s/ Gregory C. Thompson    Vice President and Corporate      September 27, 1996
  - -----------------------    Controller
  Gregory C. Thompson        (Principal Accounting Officer)
                             
  
  /s/ David A. Boucher       Director                          September 27, 1996
  - -----------------------
  David A. Boucher
  
  /s/ Michael W. Brown       Director                          September 27, 1996
  - -----------------------
  Michael W. Brown
  
  /s/ Marcia J. Hooper       Director                          September 27, 1996
  - -----------------------
  Marcia J. Hooper
  
  /s/ Joseph J. Kroger       Director                          September 27, 1996
  - -----------------------
  Joseph J. Kroger
  
  /s/ Raymond C. Kurzweil    Director                          September 27, 1996
  - -----------------------
  Raymond C. Kurzweil
  6
  /s/ Axel J. Leblois        Director                          September 27, 1996
  - -----------------------
  Axel J. Leblois
  
  /s/ Paul E. Tsongas        Director                          September 27, 1996
  - -----------------------
  Paul E. Tsongas
  
  /s/ Frederick A. Wang      Director                          September 27, 1996
  - -----------------------
  Frederick A. Wang
  7
  
                                   EXHIBIT INDEX
  4.1*    Certificate of Incorporation of the Registrant, as amended to date
  4.2*    By-Laws of the Registrant, as amended to date
  5.1     Opinion of Albert A. Notini, General Counsel of Wang Laboratories, Inc.
  23.1    Consent of Albert A. Notini, General Counsel of Wang Laboratories, 
          Inc. (included in Exhibit 5.1)
  23.2    Consent of Ernst & Young, LLP
  24.1    Power of Attorney (included on page 5 of the Registration Statement)
  - ---------------
  *       Filed as an Exhibit to the Registrant's quarterly report on 10-Q for
          the quarter ended December 31, 1995 and incorporated herein by
          reference.